GEODIS strengthens Asia Pacific healthcare logistics with GDP certification
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
GEODIS announces regional GDP certification across Asia Pacific, covering pharmaceutical freight forwarding and temperature-controlled healthcare logistics.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- IYT iShares U.S. Transportation ETF
iShares U.S. Transportation ETF: it holds transport and logistics firms. Linked by “logistics” (transport and logistics) in this story.
- BWET Breakwave Tanker Shipping ETF-3.3% 17d
Breakwave Tanker Shipping ETF: it tracks shipping freight. Linked by “freight” (container shipping) in this story.
- AAXJ iShares MSCI All Country Asia ex Japan ETF
iShares MSCI All Country Asia ex Japan ETF holds stocks listed in Asia, which this story is about (“asia”).
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLV | +6.43% | +4.39% | base | after close | after close | after close | after close |
| XBI | +4.51% | +0.86% | base | after close | after close | after close | after close |
| IYT | +3.51% | +1.81% | base | after close | after close | after close | after close |
| BWETNo price data for this ticker | — | — | — | — | — | — | — |
| AAXJ | +7.50% | +2.29% | base | after close | after close | after close | after close |
| LLY | +6.91% | +4.75% | base | after close | after close | after close | after close |
| JNJ | +7.01% | +4.30% | base | after close | after close | after close | after close |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
GEODIS strengthens Asia Pacific healthcare logistics with GDP certification Container News
Source: Container News
How far Select Sector Spdr Tr (XLV) has moved since 20 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Ishares Msci Asia Ex-Japan (AAXJ) | three days earlier | +2.29% | final price |
| Ishares Msci Asia Ex-Japan (AAXJ) | five days earlier | +7.50% | final price |
| Ishares Tr (IYT) | three days earlier | +1.81% | final price |
| Ishares Tr (IYT) | five days earlier | +3.51% | final price |
| Johnson & Johnson (JNJ) | three days earlier | +4.30% | final price |
| Johnson & Johnson (JNJ) | five days earlier | +7.01% | final price |
| Eli Lilly (LLY) | three days earlier | +4.75% | final price |
| Eli Lilly (LLY) | five days earlier | +6.91% | final price |
| Spdr Series Trust (XBI) | three days earlier | +0.86% | final price |
| Spdr Series Trust (XBI) | five days earlier | +4.51% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +4.39% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | +6.43% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 17 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 31 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 77 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 44 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 51 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 77 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies carried with this story
- XLV Select Sector Spdr Tr
For “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
- XBI Spdr Series Trust
For “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification,” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
- IYT Ishares Tr
Ishares Tr (IYT) is linked, with no stored direction, medium confidence in the 20 Nov 2026 story “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification.” Reason on file: iShares U.S. Transportation ETF: it holds transport and logistics firms. Linked by “logistics” (transport and logistics) in this story
- AAXJ Ishares Msci Asia Ex-Japan
Ishares Msci Asia Ex-Japan (AAXJ) is linked, with no stored direction, medium confidence in the 20 Nov 2026 story “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification.” Reason on file: iShares MSCI All Country Asia ex Japan ETF holds stocks listed in Asia, which this story is about (“asia”)
- UNP Union Pacific
In “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification,” Union Pacific (UNP) is linked, with no stored direction, medium confidence. Reason on file: Union Pacific (railroads, line-haul operating): freight and delivery firms move with trade volumes. Linked by “logistics” (transport and logistics) in this story
- UPS United Parcel Service
In “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification,” United Parcel Service (UPS) is linked, with no stored direction, medium confidence. Reason on file: United Parcel Service (trucking and courier services (no air)): freight and delivery firms move with trade volumes. Linked by “logistics” (transport and logistics) in this story
- LLY Eli Lilly
For “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 20 Nov 2026 story “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification.” Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
Select Sector Spdr Tr (XLV)
Select Sector Spdr Tr (XLV) is the company in “GEODIS strengthens Asia Pacific healthcare logistics with GDP certification,” the 20 Nov 2026 this story story.
For Select Sector Spdr Tr (XLV), the reason on file says Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
A second company, Spdr Series Trust (XBI), is listed for a different reason: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
A simple score for Select Sector Spdr Tr (XLV)
46 out of 100
“GEODIS strengthens Asia Pacific healthcare logistics with GDP certification” scores 46 out of 100. The score uses 1 source, and 8 linked companies.